MED-RIVASTIGMINE
GENERIC MEDICAL PARTNERS INC
Quick answers
Is there a shortage of MED-RIVASTIGMINE in Canada?
No. There is no current shortage of MED-RIVASTIGMINE 3MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
NOVO-RIVASTIGMINE
NOVOPHARM LIMITED
Other Products
EXELON
KNIGHT THERAPEUTICS INC.
PMS-RIVASTIGMINE
PHARMASCIENCE INC
APO-RIVASTIGMINE
APOTEX INC
RIVASTIGMINE TARTRATE CAPSULES
DR REDDY'S LABORATORIES LTD
MED-RIVASTIGMINE
GENERIC MEDICAL PARTNERS INC
DIN
02401622
Strength
3MG
Dosage Form
Capsule
Route
Oral
Active Ingredient
RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)
See all RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from GENERIC MEDICAL PARTNERS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02524449
1MG · DIN 02494574
50MG · DIN 02501481
20MG · DIN 02452421
10MG · DIN 02480042
1000MG · DIN 02496925
0.2% · DIN 02507811
300MG · DIN 02462664
150MG · DIN 02462656
50MG · DIN 02390760
2% · DIN 02457210
DIN 02437686